Deva


Deva Holding, established in 1958, is one of Turkey’s longest-established pharmaceutical manufacturers. It operates in the production and marketing of pharmaceuticals and pharmaceutical raw materials, with a focus on innovation, quality, and sustainability. The company has a broad product portfolio spanning multiple therapeutic areas and is committed to leading in the development of equivalent drugs. Deva Holding has manufacturing facilities in Kartepe, Çerkezköy, and a logistics center, with a strong emphasis on research and development, quality policies, and international market expansion.

Industries

Manufacturing
Medical
Pharmaceutical
Pharmaceutical Manufacturing

Nr. of Employees

Very Large (1000+)


Products

Broad finished pharmaceutical product portfolio

Extensive catalog of finished pharmaceuticals across multiple therapeutic areas offered in a variety of dosage forms including film-coated tablets, modified/extended-release tablets, capsules, soft-gels, sterile injectables, lyophilized powders and nebulization solutions; portfolio supports domestic and international supply including oncology and animal health products.

AZITRO

Oral suspension medication containing azithromycin dihydrate for systemic anti-infective use.

TRIO 14 blisters

Trio 14 blisters containing Clarithromycin-lanso.

ARTROJECT S.C. SOLUTION FOR INJECTION WITH READY TO USE PREF 10 mg/ml

Methotrexate solution for injection with ready to use prefilled syringe.

Cefaks 250 mg/5

CEFAKS 250 mg Film Coated Tablets contain Cefuroxime (as axetil) and are indicated for the treatment of various bacterial infections including upper and lower respiratory tract infections, genito-urinary system infections, and skin infections.

Cefaks 250 mg/5 ml Granules for Oral Suspension

Cefaks 250 mg/5 ml Granules for Oral Suspension is a systemic anti-infective medicine containing cefuroxime axetil.

View All Products

Services

On-site manufacture of solid, liquid, semi-solid, sterile injectable, lyophilized and inhalation dosage forms at commercial scale, including dedicated oncology and API manufacturing units.

On-site and collaborative R&D services including formulation development, API synthesis and scale-up, biotechnology research and development of generics and novel formulations.

Advisory services for regulatory submissions, product registration and market access across multiple international jurisdictions.

On-site logistics operations for temperature-controlled storage, handling and distribution of finished pharmaceutical and consumer health products.

Expertise Areas

  • Commercial pharmaceutical manufacturing (sterile and non-sterile)
  • Oncology product manufacturing (solid and sterile)
  • Formulation development and process scale-up (including modified-release)
  • Active pharmaceutical ingredient (API) synthesis and on-site API manufacturing
  • Show More (7)

Key Technologies

  • Solid oral dosage formulation and tablet/capsule production
  • Liquid formulation and sterile injectable manufacturing
  • Lyophilization (freeze-drying)
  • Aseptic filling and sterile processing
  • Show More (6)

News & Updates

The Hilal-i Ahmer Collection on show with DEVA-Tur

Annual Report 2024


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.